Trials / Active Not Recruiting
Active Not RecruitingNCT03220373
Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients
Predicting Early Treatment Termination (Dropout) and Post-treatment Clinical Outcome From Neuropsychological Functions in Abstinent Substance Use Dependent (SUD) Patients
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
The aim of this project is to gain a more specific understanding of how different cognitive profiles predict residential treatment drop-out, treatment retention and post-treatment outcome in a population with Substance Use Disorder.
Detailed description
This project collects the neuropsychological profile of residential SUD patients, in addition to treatment length, exit reason, hospital journal data and post-treatment clinical outcome data. The project aims to identify clinically relevant neurocognitive domains that predict treatment dropout and post-treatment clinical outcome. This will make it possible for future clinicians to focus their effort on neurocognitive functions most relevant for this particular patient group. RESEARCH QUESTIONS: 1. What neurocognitive domain (and sub-domain) are the strongest predictor of treatment drop-out and retention? 2. What neurocognitive domain (and sub-domain) are the strongest predictor of post-treatment clinical outcome variables such as drug use, health and social integration. 3. Will data on treatment length, age, gender, substance abuse history or psychiatric co-morbidity predict outcome independently, or in interaction with, the neuropsychological profile? This longitudinal prospective cohort study aims for a continuous collection of neuropsychological data baseline and post-treatment follow-up data until 2030.
Conditions
Timeline
- Start date
- 2017-03-07
- Primary completion
- 2029-12-31
- Completion
- 2029-12-31
- First posted
- 2017-07-18
- Last updated
- 2024-01-05
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03220373. Inclusion in this directory is not an endorsement.